CLINICAL EVALUATION OF BIS(2-CHLOROPROPYL)CARBAMIC ACID, ETHYL ESTER (6W54, NSC-53105).
D000380:Agranulocytosis; D000970:Antineoplastic Agents; D035843:Biomedical Research; D001855:Bone Marrow Diseases; D001943:Breast Neoplasms; D002219:Carbamates; D002279:Carcinoma 256, Walker; D006528:Carcinoma, Hepatocellular; D003880:Dermatology; D004285:Dogs; D005762:Gastroenterology; D005853:Geriatrics; D006801:Humans; D007970:Leukopenia; D008113:Liver Neoplasms; D009461:Neurologic Manifestations; D051381:Rats; D012106:Research; D014116:Toxicology
D000970:Antineoplastic Agents; D002219:Carbamates
AGRANULOCYTOSIS; ANTINEOPLASTIC AGENTS; BONE MARROW DISEASES; BREAST NEOPLASMS; CARBAMATES; CARCINOMA 256, WALKER; CLINICAL RESEARCH; DERMATOLOGY; DOGS; EXPERIMENTAL LAB STUDY; GASTROENTEROLOGY; GERIATRICS; HEPATOMA; LEUKOPENIA; NEUROLOGIC MANIFESTATIONS; RATS; TOXICOLOGIC REPORT